Brief: PacBio Reports Record Prelim Q4 and Full Year Revenue
Jan 8 (Reuters) - Pacific Biosciences of California Inc
PACB.O :
* PACBIO ANNOUNCES RECORD PRELIMINARY FOURTH QUARTER AND
FULL YEAR
REVENUE GROWING 113% AND 56%, RESPECTIVELY
* PACIFIC BIOSCIENCES OF CALIFORNIA: PRELIMINARY UNAUDITED
REVENUE
FOR Q4 2023 AND FULL YEAR 2023 OF $58.4 MILLION AND $200.5
MILLION RESPECTIVELY
Source text for Eikon: ID:nPn2H6Qcya
Further company coverage: PACB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pacific Biosciences of California
See all newsBrief: Pacbio And Verily Health Announce Multi-Year Strategic Collaboration
Pacific Biosciences of California, Inc. reports results for the quarter ended June 30 - Earnings Summary
Pacific Biosciences Q2 adj. loss bigger than estimates on margin pressure
Brief: Pacific Biosciences of California Q2 EPS USD -0.14
Pacific Biosciences of California Inc expected to post a loss of 13 cents a share - Earnings Preview